64 related articles for article (PubMed ID: 20636863)
1. In-vitro transdermal penetration of cytarabine and its N4-alkylamide derivatives.
Legoabe LJ; Breytenbach JC; N'Da DD; Breytenbach JW
J Pharm Pharmacol; 2010 Jun; 62(6):756-61. PubMed ID: 20636863
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and transdermal permeation of novel N4-methoxypoly(ethylene glycol) carbamates of cytarabine.
Legoabe LJ; N'Da DD; Breytenbach JC; du Preez JL; du Plessis J
Drug Dev Ind Pharm; 2010 Dec; 36(12):1477-85. PubMed ID: 20560790
[TBL] [Abstract][Full Text] [Related]
3. Transdermal penetration of cytarabine and its 5'-O alkyl ester derivatives.
Legoabe LJ; Breytenbach JC; N'Da DD; Breytenbach JW
Med Chem; 2010 Mar; 6(2):108-13. PubMed ID: 20218966
[TBL] [Abstract][Full Text] [Related]
4. Lipid based noninvasive vesicular formulation of cytarabine: Nanodeformable liposomes.
Raj R; Raj PM; Ram A
Eur J Pharm Sci; 2016 Jun; 88():83-90. PubMed ID: 27063328
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and transdermal properties of acetylsalicylic acid and selected esters.
Gerber M; Breytenbach JC; Hadgraft J; du Plessis J
Int J Pharm; 2006 Mar; 310(1-2):31-6. PubMed ID: 16442756
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of physicochemical properties, skin permeation and accumulation profiles of salicylic acid amide prodrugs as sunscreen agent.
Yan YD; Sung JH; Lee DW; Kim JS; Jeon EM; Kim DD; Kim DW; Kim JO; Piao MG; Li DX; Yong CS; Choi HG
Int J Pharm; 2011 Oct; 419(1-2):154-60. PubMed ID: 21839822
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and structure-activity studies in vivo of liposomal phospholipid-N4-palmitoyl- and N4-hexadecyl-1-beta-D-arabinofuranosylcytosine conjugates.
Schott H; Schwendener RA
Anticancer Drug Des; 1996 Sep; 11(6):451-62. PubMed ID: 8836110
[TBL] [Abstract][Full Text] [Related]
8. Synthesis of methoxypoly(ethylene glycol) carbonate prodrugs of zidovudine and penetration through human skin in vitro.
N'da DD; Breytenbach JC
J Pharm Pharmacol; 2009 Jun; 61(6):721-31. PubMed ID: 19505362
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis and characterization of captopril prodrugs for enhanced percutaneous absorption.
Moss GP; Gullick DR; Cox PA; Alexander C; Ingram MJ; Smart JD; Pugh WJ
J Pharm Pharmacol; 2006 Feb; 58(2):167-77. PubMed ID: 16451744
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and evaluation of anti-tumor activities of N4 fatty acyl amino acid derivatives of 1-beta-arabinofuranosylcytosine.
Liu B; Cui C; Duan W; Zhao M; Peng S; Wang L; Liu H; Cui G
Eur J Med Chem; 2009 Sep; 44(9):3596-600. PubMed ID: 19321234
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and transdermal penetration of NSAID glycoside esters.
Swart H; Breytenbach JC; Hadgraft J; du Plessis J
Int J Pharm; 2005 Sep; 301(1-2):71-9. PubMed ID: 16061334
[TBL] [Abstract][Full Text] [Related]
12. [Ara-C].
Onozawa M; Teshima T
Nihon Rinsho; 2015 Feb; 73 Suppl 2():623-7. PubMed ID: 25831835
[No Abstract] [Full Text] [Related]
13. Synthetic approaches to a mononucleotide prodrug of cytarabine.
Bazzanini R; Gouy MH; Peyrottes S; Gosselin G; Périgaud C; Manfredini S
Nucleosides Nucleotides Nucleic Acids; 2005; 24(10-12):1635-49. PubMed ID: 16438040
[TBL] [Abstract][Full Text] [Related]
14. Transdermal penetration of zalcitabine, lamivudine and synthesised N-acyl lamivudine esters.
Gerber M; Breytenbach JC; du Plessis J
Int J Pharm; 2008 Mar; 351(1-2):186-93. PubMed ID: 18006257
[TBL] [Abstract][Full Text] [Related]
15. Percutaneous delivery of carbamazepine and selected N-alkyl and N-hydroxyalkyl analogues.
Fourie L; Breytenbach JC; Du Plessis J; Goosen C; Swart H; Hadgraft J
Int J Pharm; 2004 Jul; 279(1-2):59-66. PubMed ID: 15234795
[TBL] [Abstract][Full Text] [Related]
16. In vitro evaluation of quercetin-3-O-acyl esters as topical prodrugs.
Montenegro L; Carbone C; Maniscalco C; Lambusta D; Nicolosi G; Ventura CA; Puglisi G
Int J Pharm; 2007 May; 336(2):257-62. PubMed ID: 17257788
[TBL] [Abstract][Full Text] [Related]
17. Transdermal behaviour of the N-alkylamide spilanthol (affinin) from Spilanthes acmella (Compositae) extracts.
Boonen J; Baert B; Roche N; Burvenich C; De Spiegeleer B
J Ethnopharmacol; 2010 Jan; 127(1):77-84. PubMed ID: 19808085
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and evaluation of esmolol prodrugs for transdermal delivery.
Bijaya G; Kaushal D; Sonal D; Pallavi K
Drug Deliv; 2010; 17(7):532-40. PubMed ID: 20553111
[TBL] [Abstract][Full Text] [Related]
19. Formulation development of transdermal dosage forms: quantitative structure-activity relationship model for predicting activities of terpenes that enhance drug penetration through human skin.
Kang L; Yap CW; Lim PF; Chen YZ; Ho PC; Chan YW; Wong GP; Chan SY
J Control Release; 2007 Jul; 120(3):211-9. PubMed ID: 17582639
[TBL] [Abstract][Full Text] [Related]
20. Dermal and transdermal delivery of an anti-psoriatic agent via ethanolic liposomes.
Dubey V; Mishra D; Dutta T; Nahar M; Saraf DK; Jain NK
J Control Release; 2007 Nov; 123(2):148-54. PubMed ID: 17884226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
